News About: Pharm. Industry
Medical representatives mistreated by doctors
A number of medical representatives are annoyed by doctors’ mistreatment in their daily detailing activities to promote ethical products.
They are often complaining about doctors’ negligence and frequent demands fo...
Taejoon appoints Choo as presidentDr. Choo Sang-un has joined Taejoon Pharm as president effective August 4.
A graduate of Hanyang University’s medical college, Choo has previously held various positions at t...
|
GCC’s OTC products gaining momentum
Green Cross Corp. says its new two products – Hansaplast plaster, first non-medicinal plaster to protect wounds and minor injuries and Taksen, analgesic & anti-inflammatory agent, are expanding market share in the dom...
New pricing criteria of chemically modified medicines draw positive reactions
The government plans to set a new pricing standard for chemically modified drugs in the latter half of this year, under consultation with the Korea Pharmaceutical Manufacturers Association, according to the Ministry o...
OTC drug makers struggling to set normal market price
Despite incessant price hike of some renowned OTC products in recent months, some of OTC makers have endeavored to firmly establish their normal prices amid cut-throat competition, according to pharmaceutical sources....
Toll manufacturing for cephalosporin antibiotics likely to steam up
The domestic toll manufacturing business for cephalosporin antibiotics will get a momentum as the Ministry of Health, Welfare and Family Affairs plans to newly separate the production of cephalosporin antibiotics from...
Korea’s pharmaceutical export surges 22%
Pharmaceutical export by Korean firms for the first half of this year recorded $591 million, growing 22 percent from a year ago.
Statistics showed that pharmaceutical bulk drugs export soared notably with $257 mill...
Ildong to build W50 bil. plantIldong Pharm says it will invest about 50.0 billion won to build a cGMP plant producing cephalosporin antibiotics and antineoplastic agents by July next year.
The plant will ...
|
Yooyoung launches alprostadil cream
Yooyoung Pharm says it has launched Befar (alprostadil) cream in Korea through its exclusive agreement with the U.S. based Nexmed Co.
Befar has shown a clinical efficacy of up to 83% in patients with varying degree...
Finding growth in generics markets
A number of domestic pharmaceutical firms have managed to increase their sales of generic products through aggressive marketing strategies, despite the local economic slowdown and falling drug prices.
"Much of the ...
